MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FREDERIKSEN, S.
Right arrow Articles by TØNNESEN, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FREDERIKSEN, S.
Right arrow Articles by TØNNESEN, T.

Molecular Pharmacology, Vol 4, 358-366, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

The Effect of Adenosine N1-Oxide on the Incorporation of Radioactive Precursors into the Nucleic Acids

SUNE FREDERIKSEN 1, ANNELISE Ø. JØRGENSEN 1, ALBERT H. RASMUSSEN 1, and TØNNE TØNNESEN 1

1 Biochemical Department B, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark

Adenosine N1-oxide is phosphorylated by Ehrlich ascites tumor cells to AMP N1-oxide and ATP N1-oxide. In Ehrlich cells incubated with adenosine N1-oxide the incorporation of thymidine-3H and 32P into DNA is inhibited. The results indicate that AMP N1-oxide or ATP N1-oxide is responsible for the inhibition. The incorporation of 32P and uridine-3H into RNA is not inhibited by the analog. The inhibitory effect of adenosine N1-oxide[unknown] on the incorporation of thymidine-3H into DNA can be abolished by the addition of 2'-deoxycytidine, cytidine, and to some extent uridine, but cytosine and 2'-deoxyguanosine have no effect on the inhibition. Adenosine N1-oxide inhibits the incorporation of adenine-3H and orotic acid-3H into both DNA and RNA. In the case of adenine-3H this is shown to be due partly to a decreased uptake of the tracer into the ATP pool.

Note:
ACKNOWLEDGMENTS The authors thank Professor H. Klenow for valuable discussions, and Mrs. Inge Kirkeby Hansen for excellent technical assistance.

Submitted on November 27, 1967
Revised on March 4, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics